Relationship Between Influenza Vaccination and COVID-19 Infection among Personnel of Shahid Beheshti Hospital in Kashan, Iran

Document Type : Original Research

Authors
H. Pahlevani 1
M. Farahnakian 1
F. S. Asgarian 2
M. Najafizadeh 1
1 Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran
2 Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, Iran
10.61186/iem.9.4.331
Abstract
Aims: Reports show that vaccination against influenza could elicit nonspecific immune reactions against coronavirus disease-19 (COVID-19). The present research aimed to evaluate the prevalence of COVID-19 disease among the staff of Shahid Beheshti hospital in Kashan despite vaccination against influenza.

Materials & Methods: This study was performed on 1400 employees of Shahid Beheshti hospital in Kashan from February to August 2020. Personnel whose disease was confirmed by PCR test or CT scan were considered to have COVID-19. In the present research, the relationship between influenza vaccination and the incidence of COVID-19 infection was evaluated. The collected data were analyzed by SPSS software Version 26.

Findings: Out of a total of 1400 hospital personnel participating in this study, 272 people were diagnosed as COVID-19. Among 272 patients, 23 (8.45%) cases were vaccinated. The average age of vaccinated patients was 33.48 ± 12.72 years, of whom 14 (60.87%) patients were female. Vaccination was significantly associated with prevention of COVID-19 infection (p< .05). The study of odds ratio (OR) to evaluate the effect of vaccination showed that the OR was 0.61 (95% CI: 0.39- 0.97). There was a significant difference in SpO2, type of treatment, and lung involvement based on CT between the two groups of vaccinated and unvaccinated COVID-19 patients (p< .05).

Conclusion: In vaccinated group, COVID-19 was lower than of the no influenza vaccinated group. According to the results, the use of influenza vaccine as an effective vaccine against the new coronavirus strains could be helpful in controlling the disease.

Keywords

1. Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K: Coronavirus disease 2019 (COVID-19): current status and future perspectives. International journal of antimicrobial agents 2020, 55(5):105951.
2. Bai L, Zhao Y, Dong J, Liang S, Guo M, Liu X, Wang X, Huang Z, Sun X, Zhang Z: Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell research 2021, 31(4):395-403.
3. Antony SJ, Almaghlouth NK, Heydemann EL: Are coinfections with COVID‐19 and influenza low or underreported? An observational study examining current published literature including three new unpublished cases. Journal of medical virology 2020, 92(11):2489-2497.
4. Huang K, Lin S-W, Sheng W-H, Wang C-C: Influenza vaccination and the risk of COVID-19 infection and severe illness in older adults in the United States. Scientific reports 2021, 11(1):1-6.
5. Taghioff SM, Slavin BR, Holton Iii LH, Singh D: The Impact of the Influenza Vaccine on Postoperative Outcomes in Covid-19 Positive Patients: An Analysis of 43,580 Patients Utilizing a Globally Federated Electronic Medical Record Network. Journal of the American College of Surgeons 2021, 233(5):S84-S85.
6. Sardinha DM, da Costa Lobato D, da Silva Ferreira AL, Lima KVB, Lima LNGC: Analysis of 472,688 severe cases of COVID-19 in Brazil showed lower mortality in those vaccinated against influenza. medRxiv 2021.
7. Amato M, Werba JP, Frigerio B, Coggi D, Sansaro D, Ravani A, Ferrante P, Veglia F, Tremoli E, Baldassarre D: Relationship between influenza vaccination coverage rate and COVID-19 outbreak: an Italian ecological study. Vaccines 2020, 8(3):535.
8. Umasabor-Bubu OQ, Bubu OM, Mbah AK, Nakeshbandi M, Taylor TN: Association between influenza vaccination and severe COVID-19 outcomes at a designated COVID-only hospital in brooklyn. American Journal of Infection Control 2021, 49(10):1327-1330.
9. Yang M-J, Rooks BJ, Le T-TT, Santiago IO, Diamond J, Dorsey NL, Mainous AG: Influenza vaccination and hospitalizations among COVID-19 infected adults. The Journal of the American Board of Family Medicine 2021, 34(Supplement):S179-S182.
10. Taghioff SM, Slavin BR, Holton T, Singh D: Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients. PLoS One 2021, 16(8):e0255541.
11. Martínez-Baz I, Trobajo-Sanmartín C, Arregui I, Navascués A, Adelantado M, Indurain J, Fresán U, Ezpeleta C, Castilla J: Influenza vaccination and risk of SARS-CoV-2 infection in a cohort of health workers. Vaccines 2020, 8(4):611.
12. Kissling E, Hooiveld M, Brytting M, Vilcu AM, de Lange M, Martínez‐Baz I, Sigerson D, Enkirch T, Belhillil S, Meijer A: Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020. Influenza and other respiratory viruses 2021, 15(4):429-438.
13. Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Emameh RZ, Falak R: Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microbial pathogenesis 2021, 152:104554.
14. Salem ML, El-Hennawy D: The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Medical Hypotheses 2020, 140:109752.
15. Zanettini C, Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, Marchionni L: Influenza Vaccination and COVID19 Mortality in the USA. MedRxiv 2020.
16. Grohskopf LA, Liburd LC, Redfield RR: Addressing influenza vaccination disparities during the COVID-19 pandemic. Jama 2020, 324(11):1029-1030.
17. Chen AT, Stacey HD, Marzok A, Singh P, Ang J, Miller MS, Loeb M: Effect of inactivated influenza vaccination on human coronavirus infection: secondary analysis of a randomized trial in Hutterite colonies. Vaccine 2021, 39(48):7058-7065.
18. Kalantari S, Sadeghzadeh-Bazargan A, Ebrahimi S, Yassin Z, Faiz SHR, Kabir A, Baghestani A, Mashayekhi F, Bokharaei-Salim F, Goodarzi A: The effect of influenza vaccine on severity of COVID-19 infection: An original study from Iran. Medical Journal of the Islamic Republic of Iran 2021, 35:114.
19. Grech V, Borg M: Influenza vaccination in the COVID-19 era. Early human development 2020, 148:105116.
20. Skowronski DM, Zou M, Clarke Q, Chambers C, Dickinson JA, Sabaiduc S, Olsha R, Gubbay JB, Drews SJ, Charest H: Influenza vaccine does not increase the risk of coronavirus or other noninfluenza respiratory viruses: retrospective analysis from Canada, 2010–2011 to 2016–2017. Clinical Infectious Diseases 2020, 71(16):2285-2288.
21. Stańczak-Mrozek KI, Sobczak A, Lipiński L, Sienkiewicz E, Makarewicz D, Topór-Mądry R, Pinkas J, Sierpiński RA: The potential benefits of the influenza vaccination on COVID-19 mortality rate—A retrospective analysis of patients in Poland. Vaccines 2021, 10(1):5.
Infection Epidemiology and Microbiology
Volume 9, Issue 4
December 2023
Pages 331-338